In China, FHI 360 collaborates closely with the government and other key partners to address health and development issues; design cutting-edge, critical interventions; and increase the demand for, and availability of, health care services.
FHI 360 has supported the government in strengthening services to combat HIV and AIDS, sexually transmitted infections (STIs) and tuberculosis (TB) and to promote reproductive health. Our HIV programs have provided training and support that helps reduce the risk of HIV and STIs among key populations, while tackling discrimination and stigma toward men who have sex with men and injecting drug users.
FHI 360 in China also provides the most state-of-the-art responses to TB. We partner with local organizations, private health clinics and pharmacies to strengthen testing, referral and treatment services for multidrug-resistant TB. We also build the capacity of local organizations to effectively detect, monitor and treat multidrug-resistant TB.